Welcome To The Calyx Bio-Ventures HUB On AGORACOM
Edit this title from the Fast Facts Section
Message: Prees Release of Dec 2nd 2009
FOR IMMEDIATE RELEASE
Calyx Announces that Agrisoma Biosciences Inc., Dow AgroSciences have entered into a
Collaborative Research and Commercial Option Agreement for Engineered Agricultural
Crops
North Vancouver, British Columbia, Canada - (December 2, 2009) -–
Calyx Bio-Ventures Inc.
(TSX-V: CYX) (“Calyx” or the “Company”), Agrisoma Biosciences, Inc. (“Agrisoma”) and Dow
AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW),
have announced the signing of a Collaborative Research and Commercial Option agreement
between Dow AgroSciences and Agrisoma. The agreement provides Dow AgroSciences with
access to Agrisoma’s proprietary Engineered Trait Loci (ETL) technology on an exclusive basis in
major food crops, and on a non-exclusive basis, in other crop species. Calyx has 29 percent of
the equity of Agrisoma and $895,071 of secured convertible promissory notes.
Agrisoma and Dow AgroSciences have made the following announcement:
Dow AgroSciences and Agrisoma have collaborated since 2004 in the area of high value
protein production in plants and plant cell cultures. The initial collaboration formed the
foundation of a successful relationship. This new agreement builds on that relationship
and expands use of the ETL technology into field crops.
“Dow AgroSciences' strategic investment in Agrisoma’s ETL technology will accelerate
the creation of new and novel products in crop plants, such as increased levels and
improved forms of healthier oils or other beneficial food components,” said Dan Kittle,
Ph.D., Dow AgroSciences vice president for R&D. “ETL technology will be an important
tool in our ‘toolbox’ to deliver differentiated solutions enabled by the expression of
multiple genes or enhancements in complex biochemical pathways.”
Agrisoma’s ETL technology is a patent protected, broadly applicable technology that
facilitates the placement of new traits in the native genome of a crop. The ETL
technology has been used to engineer oil composition, oil content and yield for the
renewable energy market and ETL-engineered crops are now undergoing a second year
of field trials at multiple locations.
"We recognize Dow AgroSciences as a premiere global leader in plant biotechnology and
are tremendously excited about the opportunity to expand our collaboration with Dow
AgroSciences," said Steven Fabijanski, Agrisoma’s president and chief executive officer.
"Agrisoma has demonstrated the utility, stability and performance of our ETL technology
in a broad range of crops, including important food crops such as soybeans and canola.
Our ETL technology has proven performance, and through this new collaboration with
Dow AgroSciences, we hope to be able to commercialize this technology in major global
food crops. The research collaboration with Dow AgroSciences complements our
industrial crop program which is focused on creating renewable feedstocks using
dedicated bioenergy plants.”
About Calyx-Bioventures Inc.
Calyx Bio-Ventures Inc. is the successor company to Chromos Molecular Systems Inc.
(“Chromos”). Chromos was a Canadian biotechnology company that commenced operations in
1996 to pursue the development and commercialization of its proprietary ACE (Artificial
Chromosome Expression) System technology. Agrisoma was created initially as a spinoff
company from Chromos and licensed technology relevant to plants. Chromos completed a Plan
of Arrangement” in 2008 in terms of which Calyx was incorporated by Chromos as part of the
corporate reorganization process. Pursuant to the Plan of Arrangement, on June 30, 2008, Calyx
acquired all of Chromos’ assets, including the investment in and license to Agrisoma and
assumed all of Chromos’ liabilities and obligations.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release
Cautionary Note Regarding Forward-Looking Statements
Except for the statements of historical fact contained herein, the information presented constitutes “forward
looking statements”. Such forward-looking statements, including but not limited to those with respect to the
direct and indirect benefits to Agrisoma and the Company as a result of the agreement between Agrisoma
and Dow AgroSciences, uncertainties and other factors which may cause the actual results, performance or
achievements of the Company or Agrisoma to be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements. Although the Company has
attempted to identify important factors that could cause actual results to differ materially, there may be other
factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that
such statements will prove to be accurate, as actual results and future events could differ materially from
those anticipated in such statements. Accordingly, readers should not place undue reliance on forwardlooking
statements.
1 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply